TABLE 4.

Psychosocial Standards: Neuropsychological monitoring and adherence to treatment ⁷⁸

Standard	Care Delivery	%
PSS2: Patients with brain tumors and others at high risk for neuropsychological deficits … should be monitored for neuropsychological deficits during and after treatment	Referral to a Neuropsychologist	84.5
	Informal Discussion	77.6
	Brief Neurocognitive Screen	30.2
	When is this care delivered?
	When a problem was identified	87.9
	At survivorship visits	53.4
	At the end of treatment	50.0
PSS12: Adherence should be assessed routinely and monitored throughout treatment	Ask the patient	96.4
	Ask family members	69.0
	Self-report measures/patients	80.5
	Self-report measures/parents	79.6
	Self-report measures/staff	72.6
	Blood test	40.7
	Monitoring Systems (MEMS) or similar	4.4

⁷Based on respondents answering each question. n’s ranged from 113–118.

⁸Responses allowed for multiple answers (“check all that apply”)